Ignite Creation Date:
2025-12-25 @ 1:33 AM
Ignite Modification Date:
2026-05-13 @ 3:37 PM
Study NCT ID:
NCT00036894
Status:
COMPLETED
Last Update Posted:
2015-04-30
First Post:
2002-05-13
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
CC-5013 in Treating Patients With Recurrent Glioma
Sponsor:
National Cancer Institute (NCI)
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Brain and Central Nervous System Tumors | View |
Keywords:
Keywords
| Keyword Brief | Keyword Text | View |
|---|---|---|
| None | recurrent adult brain tumor | View |
| None | adult glioblastoma | View |
| None | adult anaplastic astrocytoma | View |
| None | adult anaplastic oligodendroglioma | View |
| None | adult mixed glioma | View |
| None | adult ependymoblastoma | View |
| None | adult anaplastic ependymoma | View |
| None | adult myxopapillary ependymoma | View |
| None | adult meningioma | View |
| None | adult meningeal hemangiopericytoma | View |
| None | adult brain stem glioma | View |
| None | adult grade III meningioma | View |
| None | adult giant cell glioblastoma | View |
| None | adult gliosarcoma | View |